HomeComparePHYOF vs SCHD

PHYOF vs SCHD: Dividend Comparison 2026

PHYOF yields 2857.14% · SCHD yields 3.44%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PHYOF wins by $285724556560.05M in total portfolio value
10 years
PHYOF
PHYOF
● Live price
2857.14%
Share price
$0.07
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$285724556560.08M
Annual income
$267,319,527,558,731,650.00
Full PHYOF calculator →
SCHD
Schwab U.S. Dividend Equity ETF
● Live price
3.44%
Share price
$30.65
Annual div
$1.06
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$29.0K
Annual income
$423.11
Full SCHD calculator →

Portfolio growth — PHYOF vs SCHD

📍 PHYOF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPHYOFSCHD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PHYOF + SCHD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PHYOF pays
SCHD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PHYOF
Annual income on $10K today (after 15% tax)
$242,857.14/yr
After 10yr DRIP, annual income (after tax)
$227,221,598,424,921,900.00/yr
SCHD
Annual income on $10K today (after 15% tax)
$292.77/yr
After 10yr DRIP, annual income (after tax)
$359.64/yr
At 15% tax rate, PHYOF beats the other by $227,221,598,424,921,540.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PHYOF + SCHD for your $10,000?

PHYOF: 50%SCHD: 50%
100% SCHD50/50100% PHYOF
Portfolio after 10yr
$142862278280.06M
Annual income
$133,659,763,779,366,030.00/yr
Blended yield
93.56%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PHYOF buys
0
SCHD buys
3
PoliticianChamberTickerTypeAmountDate
Virginia Foxx🏢 House$SCHD▼ Sell$50,001 - $100,0002023-03-08
Steve Cohen🏢 House$SCHD▲ Buy$50,001 - $100,0002022-07-29
Hakeem S. Jeffries🏢 House$SCHD▲ Buy$15,001 - $50,0002021-04-12
Mikie Sherrill🏢 House$SCHD▲ Buy$100,001 - $250,0002020-02-21
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPHYOFSCHD
Forward yield2857.14%3.44%
Annual dividend / share$2.00$1.06
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$285724556560.08M$29.0K
Annual income after 10y$267,319,527,558,731,650.00$423.11
Total dividends collected$284448663636.43M$3.9K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: PHYOF vs SCHD ($10,000, DRIP)

YearPHYOF PortfolioPHYOF Income/yrSCHD PortfolioSCHD Income/yrGap
1← crossover$296,414$285,714.29$11,224$344.44+$285.2KPHYOF
2$8,232,097$7,914,934.20$12,568$355.34+$8.22MPHYOF
3$214,243,566$205,435,221.63$14,039$365.68+$214.23MPHYOF
4$5,225,999,702$4,996,759,086.15$15,650$375.46+$5225.98MPHYOF
5$119,502,966,841$113,911,147,159.88$17,412$384.69+$119502.95MPHYOF
6$2,562,267,139,226$2,434,398,964,706.24$19,338$393.38+$2562267.12MPHYOF
7$51,522,962,512,220$48,781,336,673,248.19$21,441$401.55+$51522962.49MPHYOF
8$971,869,901,477,056$916,740,331,588,980.50$23,737$409.22+$971869901.45MPHYOF
9$17,200,961,683,505,388$16,161,060,888,924,940.00$26,242$416.39+$17200961683.48MPHYOF
10$285,724,556,560,082,430$267,319,527,558,731,650.00$28,975$423.11+$285724556560.05MPHYOF

PHYOF vs SCHD: Complete Analysis 2026

PHYOFStock

IXICO plc provides data analytics services to the biopharmaceutical industry in the United Kingdom, Switzerland, Netherlands, Ireland, rest of Europe, the United States, and internationally. Its services include collection, analysis, management, and reporting on data generated in the course of a clinical study. The company's technologies comprise Assessa, a secure online digital platform that provides clinical decision support for patient selection and post-marketing surveillance; and TrialTracker, a platform that delivers imaging services designed to manage the complex imaging workflow from image upload, quality control, and reading/analysis to reporting and data transfer. Its focused therapeutic areas include Alzheimer's, Parkinson's, Huntington's, Multiple Sclerosis and other demyelinating diseases, Progressive Supranuclear Palsy, and other rare neurological diseases. The company also engages in the data collection, optimization, and analytics of rare neurological disorders; offers drug development analytics, imaging operation services, and post marketing surveillance services, as well as consultancy services; and provides end-to-end services, such as trail design and consultation, project management, imaging site set-up and management, data management, reading and analysis, and regulatory pathway. IXICO plc was incorporated in 1995 and is based in London, the United Kingdom.

Full PHYOF Calculator →

SCHDETF

The fund’s goal is to track as closely as possible, before fees and expenses, the total return of the Dow Jones U.S. Dividend 100 Index.

Full SCHD Calculator →
📬

Get this PHYOF vs SCHD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PHYOF vs JEPIPHYOF vs OPHYOF vs KOPHYOF vs MAINPHYOF vs VYMPHYOF vs DGROPHYOF vs VIGPHYOF vs HDV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.